Biotech Values

[DewDiligence]

Re: Daxxify duration of effect

This topic has been broached in a thread two months ago—see #msg-170325372 and #msg-170328533.

Patients and injectors will, of course, make their own assessments of Daxxify’s duration of effect, regardless of how RVNC promotes the product. Still, as noted in #msg-170775983, I would prefer that RVNC use a soft sell, minimizing the likelihood of dissatisfied customers and injectors.

Daxxify is a great product that will “sell itself” in due course, so RVNC should take care to circumvent the overpromise/underdeliver pitfall.